BRCA2 and ovarian cancer: A total of 281 samples were found to be CNV-negative, while 11 patients with ovarian cancer (No. 1–5, 7–12) and one patient with pancreatic cancer (No. 6) were identified to carry CNVs in BRCA1 or BRCA2 genes by MS assay (Figure 2).